Monoclonal Antibody News and Research

RSS
Monoclonal antibodies (MAbs) are produced from a single B cell clone and can bind to a single type of antigen binding site. MAbs are homogenous antibodies that cannot form lattices with monomeric proteins as they can bind to only a single epitope on the antigen. Developed in the 1970s, MAbs can be produced against any given substance. Thus they can be used to detect and purify any substance of interest. This has made MAbs a powerful tool of molecular biology, biochemistry, and medicine.
FDA revokes EUA for monoclonal antibody therapy bamlanivimab to treat patients with COVID-19

FDA revokes EUA for monoclonal antibody therapy bamlanivimab to treat patients with COVID-19

FDA approves immunotherapy for first-line treatment of advanced gastric cancer

FDA approves immunotherapy for first-line treatment of advanced gastric cancer

Self-assembling nanofibers can help limit damage caused by inflammatory diseases

Self-assembling nanofibers can help limit damage caused by inflammatory diseases

Early monoclonal antibody therapies beneficial for COVID-19, finds study

Early monoclonal antibody therapies beneficial for COVID-19, finds study

Risk of E.R. visit or hospitalization 82% lower in mAbs-treated SARS-CoV-2 patients: Study

Risk of E.R. visit or hospitalization 82% lower in mAbs-treated SARS-CoV-2 patients: Study

A host of mutations could compromise COVID-19 vaccines and antibody therapies

A host of mutations could compromise COVID-19 vaccines and antibody therapies

Alpaca nanobodies effective against South African SARS-CoV-2 variant

Alpaca nanobodies effective against South African SARS-CoV-2 variant

Clinical trial of monoclonal antibody for treating respiratory disease in COVID-19 patients begins

Clinical trial of monoclonal antibody for treating respiratory disease in COVID-19 patients begins

Researchers identify several novel SARS-CoV-2 inhibitors

Researchers identify several novel SARS-CoV-2 inhibitors

Researchers discover a new monoclonal antibody that is effective against SARS-CoV-2 variants

Researchers discover a new monoclonal antibody that is effective against SARS-CoV-2 variants

Bispecific antibodies neutralize SARS-CoV-2 and its variants

Bispecific antibodies neutralize SARS-CoV-2 and its variants

Evidence of monoclonal antibodies effectively neutralizing SARS-CoV-2 variants

Evidence of monoclonal antibodies effectively neutralizing SARS-CoV-2 variants

Researchers evaluate antibodies that inhibit SARS-CoV-2 RBD variants with a novel assay

Researchers evaluate antibodies that inhibit SARS-CoV-2 RBD variants with a novel assay

Infliximab may hinder the effectiveness of some COVID-19 vaccines

Infliximab may hinder the effectiveness of some COVID-19 vaccines

Vaccine-induced 2C08 antibody protects against SARS-CoV-2 variants

Vaccine-induced 2C08 antibody protects against SARS-CoV-2 variants

Have scientists found SARS-CoV-2's Achilles' heel?

Have scientists found SARS-CoV-2's Achilles' heel?

mRNA vaccines and monoclonal antibodies protect against new NYC-B.1.526 variant

mRNA vaccines and monoclonal antibodies protect against new NYC-B.1.526 variant

Scientists share insights on operationalizing monoclonal antibody therapy for COVID-19

Scientists share insights on operationalizing monoclonal antibody therapy for COVID-19

Scientists estimate the amount of peanut protein that will elicit an allergic reaction

Scientists estimate the amount of peanut protein that will elicit an allergic reaction

Study shows substantial benefit of combination therapy for advanced Marburg infections

Study shows substantial benefit of combination therapy for advanced Marburg infections